EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, N. J.
Right arrow Articles by Walker, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, N. J.
Right arrow Articles by Walker, J. W.
Experimental Biology and Medicine 231:882-887 (2006)
© 2006 Society for Experimental Biology and Medicine


HEART

Endothelin-1 Mobilizes Profilin-1–Bound PIP2 in Cardiac Muscle

Nathan J. Evans and Jeffery W. Walker1

Department of Physiology, University of Wisconsin–Madison, Madison, Wisconsin 53706

To whom requests for reprints should be addressed at 1 Department of Physiology, University of Wisconsin, 1300 University Avenue, Madison, WI 53706. E-mail: jwalker{at}physiology.wisc.edu

Abstract

Phosphatidylinositol 4,5-bisphosphate (PIP2) is a key down-stream substrate of the endothelin signaling pathway and plays a role in regulating protein function at the membrane-cytoskel-etal interface. However, the dynamic properties of distinct pools of PIP2 are poorly understood, especially for PIP2 that is bound to cytoskeletal proteins. We investigated the effects of endothelin-1 (ET-1) stimulation on protein-bound PIP2 in cardiac muscle. Isolated rat myocytes and homogenized mouse ventricles were exposed to 10 nM ET-1 for varying time periods and protein-bound PIP2 was analyzed using an anti-PIP2 antibody and Western blotting. Several cytoskeletal proteins were found to contain tightly bound PIP2, including profilin-1 (~15 kDa), capZ (~32 kDa), gCap39, (~39 kDa) and {alpha}-actinin (~106 kDa). Interestingly, ET-1 pretreatment reduced the amount of PIP2 bound to profilin-1 by 46% after 15 mins, followed by a recovery to near basal levels after 60 mins. ET-1 had no effect on capZ-, gCap39-, or {alpha}-actinin–bound PIP2 levels. To further explore the dynamics of PIP2 binding, brefeldin-A (BFA) was used to disrupt PIP2 binding to ADP-ribosylation factors and to impair receptor internalization. Pretreatment with 1 µM BFA increased the PIP2 signal on profilin-1 x54% after 15 mins, followed by a decline to subbasal levels after 60 mins. Like ET-1, BFA had no effect on levels of PIP2 bound to capZ or to {alpha}-actinin. Taken together, the data indicate that profilin-1 binds PIP2 dynamically and may serve as a key regulator of the balance between cytoskeletal integrity and PIP2 availability for Ca2+/PKC signaling in the heart.

Key Words: brefeldin-A • {alpha}-actinin • phosphoinositides




This article has been cited by other articles:


Home page
FASEB J.Home page
E. Syriani, A. Gomez-Cabrero, M. Bosch, A. Moya, E. Abad, A. Gual, X. Gasull, and M. Morales
Profilin induces lamellipodia by growth factor-independent mechanism
FASEB J, May 1, 2008; 22(5): 1581 - 1596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.